Sun Pharma’s arm collaborates with HitGen

13 Mar 2019 Evaluate

Sun Pharmaceutical Industries’ research arm Sun Pharma Advanced Research Company (SPARC) has collaborated with China’s biotech firm HitGen to identify novel small molecule leads for targets of interest. Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×